ClinicalTrials.govpublic full text
RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer
head & neck cancer, cisplatin, rad001, taxotere (docetaxel), 09-028, squamous cell carcinoma, local-regional advanced head and neck, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 886500
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.